āĻšā§āĻŽNSIS-B âĸ CPH
add
Novozymes A/S
ā§Ēā§Ļā§¯.ā§Ģā§Ļ kr
ā§Ģ āĻĢā§āĻŦ, ā§Ģ:ā§§ā§¯:ā§Ģā§¯ PM GMT +ā§§ · DKK · CPH · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻ
āĻĒāĻ°āĻŋāĻŦā§āĻļ āĻ¸āĻāĻ°āĻā§āĻˇāĻŖā§āĻ° āĻāĻžāĻā§ āĻ
āĻā§āĻ°āĻāĻŖā§āĻ¯ āĻ¸āĻāĻ¸ā§āĻĨāĻžDK-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋ
āĻĒāĻ°āĻŋāĻŦā§āĻļ āĻ¸āĻāĻ°āĻā§āĻˇāĻŖā§āĻ° āĻāĻžāĻā§ āĻ
āĻā§āĻ°āĻāĻŖā§āĻ¯ āĻ¸āĻāĻ¸ā§āĻĨāĻžDK-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋāĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Ēā§Ļā§Ģ.ā§Ēā§ĻÂ kr
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§Ēā§Ļā§¨.ā§Ļā§Ļ kr - ā§Ēā§Ļā§¯.ā§Ģā§Ļ kr
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§Šā§ā§Ģ.ā§¯ā§Ļ kr - ā§Ēā§Žā§Ģ.ā§¯ā§Ļ kr
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§§ā§ā§§.ā§Ļā§ŽāĻā§ DKK
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§Ē.ā§Žā§ŽÂ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
CPH
āĻŦāĻžāĻāĻžāĻ° āĻ¸āĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (EUR) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§¯ā§§.ā§Ģā§ŽÂ āĻā§ | ā§Ŧā§§.ā§ā§Ļ% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§¨ā§.ā§§ā§ŽÂ āĻā§ | ā§Ģā§¨.ā§Ŧā§¨% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Š.ā§¨ā§Ļ āĻā§ | -ā§Ŧā§Ļ.ā§ā§¨% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | ā§Š.ā§Ēā§¯ | -ā§ā§Ģ.ā§ā§Ļ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
EBITDA | ā§§ā§Ģ.ā§Ļā§¯Â āĻā§ | -ā§§ā§Ŧ.ā§Ģā§Ļ% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§¨ā§¯.ā§Ļā§Ļ% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (EUR) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§¨ā§Ŧ.ā§Ļā§ŽÂ āĻā§ | ā§Žā§Ģ.ā§Šā§Ģ% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§§ā§Ģ.ā§¨ā§ĢāĻļāĻ¤Â āĻā§ | ā§Šā§Ļā§¨.ā§Ēā§Š% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ēā§¨ā§Ē.ā§ā§¨Â āĻā§ | ā§§ā§§ā§¯.ā§¨ā§Š% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§§.ā§Ļā§ĻāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§¨ā§.ā§ā§¯Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§§ā§Ļ.ā§¨ā§Ē | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§§.ā§Žā§Š% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | ā§¨.ā§§ā§Ģ% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (EUR) | āĻā§āĻ¨ ā§¨ā§Ļā§¨ā§Ēinfo | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | ā§Š.ā§¨ā§Ļ āĻā§ | -ā§Ŧā§Ļ.ā§ā§¨% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§¨ā§Ŧ.ā§Ēā§Ļ āĻā§ | ā§ā§Ē.ā§Ļā§§% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§¨.ā§ā§Ē āĻā§ | ā§ā§Ļ.ā§¯ā§Ž% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | -ā§§ā§Ž.ā§Ŧā§Â āĻā§ | -ā§¨ā§Ļā§Ģ.ā§§ā§Ļ% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Ģ.ā§Ģā§Ŧ āĻā§ | ā§¯ā§Ļā§¨.ā§Ģā§Ŧ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§§.ā§ā§Ŧ āĻā§ | ā§Ŧā§Ž.ā§Žā§% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Novozymes A/S was a global biotechnology company headquartered in BagsvÃĻrd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§¨ā§Ļā§Ļā§Ļ
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§ā§Ļ,ā§Ēā§Ģā§¨
